Related Experiment Video
Updated: Jun 6, 2026
07:25
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Novel methods to assess bioequivalence
Vangelis Karalis1, Mira Symillides, Panos Macheras
1Faculty of Pharmacy, National and Kapodistrian University of Athens, Laboratory of Biopharmaceutics-Pharmacokinetics, Panepistimiopolis, 15771, Athens, Greece. vkaralis@pharm.uoa.gr
Expert Opinion on Drug Metabolism & Toxicology
|December 2, 2010
Summary
Bioequivalence studies ensure two drug products with the same active ingredient perform similarly in vivo. This review covers methods, regulatory aspects, and challenges like high variability and biosimilars for drug safety and efficacy.
Area of Science:
- Pharmacokinetics and Drug Development
- Regulatory Science
Background:
- Bioequivalence (BE) studies are crucial for assessing in vivo equivalence of generic drug products.
- Ensuring therapeutic equivalence minimizes risks and optimizes healthcare costs.
Purpose of the Study:
- To review the classic bioequivalence assessment approach.
- To discuss special considerations including metabolites, highly variable drugs, and regulatory landscapes in North America and Europe.
- To explore advanced methods for high variability drugs and the emerging field of biosimilars.
Main Methods:
- Review of established bioequivalence methodologies.
- Analysis of regulatory guidelines and special case considerations.
- Discussion of advanced statistical approaches and biowaiver concepts.
Main Results:
- Readers will understand the necessity and execution of bioequivalence studies.
- Key challenges such as high drug variability and the role of metabolites are addressed.
- Current regulatory standards and innovative solutions are presented.
Conclusions:
- Bioequivalence studies are essential for guaranteeing comparable in vivo drug performance.
- Appropriate clinical studies ensure drug safety and efficacy with reduced costs and human exposure.
- Understanding bioequivalence is vital for drug developers and regulatory bodies.
Related Concept Videos
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
01:17Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:16Bioequivalence: Overview
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...